Download:
pdf |
pdfPrint Date: 9/29/20
Title:
Blood Lead Surveillance System (BLSS) -- OMB No. 0920-0931
Project Id:
0900f3eb81bcf99b
Accession #:
NCEH-LPPEHTB-8/31/20-cf99b
Project Contact:
Courtney_Joseph (hzc2)
Organization:
NCEH/ATSDR/DEHSP/LPPEHTB
Status:
Pending Regulatory Clearance
Intended Use:
Project Determination
Estimated Start Date:
08/31/2020
Estimated Completion Date:
09/30/2020
CDC/ATSDR HRPO/IRB Protocol #:
0920-0931
OMB Control #:
Determinations
Determination
Justification
HSC:
Does NOT Require HRPO
Review
Not Research - Public Health Surveillance
PRA:
PRA Applies
Completed
Entered By & Role
9/29/20
Lawler_Tameka (giq3) CIO HSC
9/29/20
Lawler_Tameka (giq3) CIO OMB / PRA
45 CFR 46.102(l)(2)
Description & Funding
Description
Priority:
Standard
Date Needed:
09/30/2020
Determination Start Date:
09/02/20
Description:
This CDC information collection request (ICR) includes two data collection systems that provide a coordinated, comprehensive, and
systematic public health approach to the surveillance and monitoring of blood lead levels (BLLs) for children and occupationally
exposed adults in the U.S. We are requesting an extension for the current OMB approval which expires on May 31, 2021 (# 09200931).
IMS/CIO/Epi-Aid/Chemical Exposure Submission:
No
IMS Activation Name:
Not selected
CIO Emergency Response Name:
Not selected
Epi-Aid Name:
Not selected
Assessment of Chemical Exposure Name:
Not selected
Goals/Purpose
We are requesting an extension for the current OMB approval for BLSS which expires on May 31, 2021.
Objective:
The overarching goal of this information collection is to continue the blood lead surveillance collection for children and
occupationally-exposed adults in the U.S.
Activities or Tasks:
Secondary Data or Specimen Analysis
Target Populations to be Included/Represented:
Children, Other
Tags/Keywords:
Lead Poisoning, Nervous System, Childhood, Lead Poisoning, Nervous System, Adult, Public Health Surveillance
CDC's Role:
CDC employees or agents will obtain or use anonymous or unlinked data or biological specimens, CDC employees will provide
substantial technical assistance or oversight, CDC is providing funding
Method Categories:
Surveillance Support
Methods:
State and local health departments submit standardized Childhood Blood Lead Surveillance (CBLS) data on a quarterly basis via
the CDC#s Secure Access Management System#s (SAMS) Secure Data eXchange#s (SDX) integrated Managed File Transfer
(MFT) Platform. CDC staff import and store the CBLS data on a secure CDC network drive for processing, analysis, and generation
of reports. State health and labor departments submit Adult Blood Lead Epidemiology and Surveillance (ABLES) data on an annual
basis through secure encrypted FTP sites. ABLES data are stored on secure CDC network drives for processing, analysis, and
generation of reports.
CDC does not collect these data directly, they are submitted by the states and local programs as described in the Methods above.
CBLS collects all laboratory and clinician-reported blood lead levels (BLLs) test results on individual children reported to
participating state or local CLPPPs. The de-identified, individual-level case management and follow-up data are forwarded to CDC,
Collection of Info, Data or Biospecimen:
Expected Use of Findings/Results:
imported into CBLS, and a consistent #case# definition is then applied. The Adult Blood Lead Epidemiology and Surveillance
(ABLES) program, a part of CDC#s NIOSH, compiles state surveillance data for adults 16 years of age or greater, most of whom
are occupationally exposed.
Data generated and analyzed from these two programs provide critical information to monitor trends in BLLs over time. This
information is used for program implementation, policy development, and to target population-based interventions to children at high
risk for lead exposure and adults who may be exposed to lead in the workplace.
Could Individuals potentially be identified based on
Information Collected?
Yes
Will PII be captured (including coded data)?
Yes
Does CDC have access to the identifiers?
No
Is an assurance of confidentiality in place or
planned?
No
Is a certificate of confidentiality in place or planned? No
Is there a formal written agreement prohibiting the
release of identifiers?
No
Funding
Funding Type
Funding Title
Funding #
CDC Cooperative
Agreement
Childhood Lead Poisoning Prevention Projects, State and Local Childhood Lead Poisoning Prevention and
Surveillance of Blood Lead Levels in Children
CDC Cooperative
Agreement
Lead Poisoning Prevention-Childhood Lead Poisoning Prevention
HSC Review
Regulation and Policy
Original
Budget Yr
# Years
Award
CDC-RFA-EH181806 SUPP20
2018
1
CDC-RFA-EH171701SUPP20
2017
1
Regulation and Policy
Do you anticipate this project will be submitted to
the IRB office
No
Estimated number of study participants
Population - Children
Population - Minors
Population - Prisoners
Population - Pregnant Women
Population - Emancipated Minors
Suggested level of risk to subjects Do you anticipate this project will be exempt research or non-exempt research
Requested consent process waviers
Informed consent for adults
No Selection
Children capable of providing assent
No Selection
Parental permission
No Selection
Alteration of authorization under HIPPA Privacy
Rule
No Selection
Requested documents of informed consent
Informed consent for adults
No Selection
Children capable of providing assent
No Selection
Parental permission
No Selection
Consent process shown in an understandable language
Reading level has been estimated
No Selection
Comprehension tool is provided
No Selection
Short form is provided
No Selection
Translation planned or performed
No Selection
Certified translation / translator
No Selection
Translation and back-translation to/from target
language(s)
No Selection
No Selection
Other method
Clinical Trial
Involves human participants
No Selection
Assigned to an intervention
No Selection
Evaluate the effect of the intervention
No Selection
Evaluation of a health related biomedical or
behavioral outcome
No Selection
Registerable clinical trial
No Selection
Other Considerations
Exception is requested to PHS informing those
bested about HIV serostatus
No Selection
Human genetic testing is planned now or in the
future
No Selection
Involves long-term storage of identfiable biological
specimens
No Selection
Involves a drug, biologic, or device
No Selection
Conducted under an Investigational New Drug
exemption or Investigational Device Exemption
No Selection
Institutions & Staff
Institutions
Institutions yet to be added .....
Staff
Staff
Member
SIQT
Exp.
Date
Benjamin
03/18
CITI
Biomedical
Exp. Date
CITI Social &
Behavioral Exp.
Date
CITI Good Clinical
Practice Exp. Date
Staff
Role
Email
Phone
Technical
yhp5@cdc.
770488-
Organization
OFFICE OF FINANCIAL INFORMATION SYSTEMS
Bina
/2023
Monitor
gov
2093
David Wall
12/18
/2022
Technical
Monitor
dkw0@cdc.
gov
5138414331
HEALTH INFORMATICS BRANCH
John Lu
08/17
/2023
Technical
Monitor
czl5@cdc.
gov
513841-5
HEALTH INFORMATICS BRANCH
Joseph
Courtney
08/31
/2023
Program
Lead
hzc2@cdc.
gov
4044983282
LEAD POISONING PREVENTION AND
ENVIRONMENTAL HEALTH TRACKING BRANCH
KATHRYN
EGAN
03/25
/2022
Technical
Monitor
nky9@cdc.
gov
4047185778
EPIDIMIOLOGY AND SURVEILLANCE
Marie
Haring
Sweeney
11/22
/2022
Program
Lead
mhs2@cdc.
gov
5138414102
HEALTH INFORMATICS BRANCH
Monica
Leonard
08/31
/2023
Program
Lead
zgf7@cdc.
gov
4044981826
DIVISION OF ENVIRONMENTAL HEALTH
SCIENCE AND PRACTICE
Qaiyim
Harris
06/09
/2023
Technical
Monitor
qah3@cdc.
gov
7704887115
EPIDIMIOLOGY AND SURVEILLANCE
Rebecca
Tsai
12/14
/2021
Technical
Monitor
vht5@cdc.
gov
5138414398
HEALTH INFORMATICS BRANCH
Scott Henn
03/04
/2022
Technical
Monitor
ajn4@cdc.
gov
5138414173
HEALTH INFORMATICS BRANCH
Stella Chuke
08/31
/2023
Technical
Monitor
slc7@cdc.
gov
7704883475
EPIDIMIOLOGY AND SURVEILLANCE
Data
DMP
11/07/2021
11/30/2021
12/16/2022
11/06/2021
Proposed Data Collection Start Date:
6/1/21
Proposed Data Collection End Date:
5/31/24
Proposed Public Access Level:
Public
Public Access Justification:
This is a publicly funded program to help state and local programs collect important data. Sharing the aggregate data with the public
is an important part of the process.
How Access Will Be Provided for Data:
Both the CBLS and ABLES data will be disseminated on program websites and in MMWR Surveillance Reports. Because CBLS
datasets include some required variables with potentially personally identifiable information (PII) (e.g., age, race, sex, county of
address) which may present privacy concerns due to small numbers for some of the variables, small cell sizes (counts <5) will be
redacted from all datasets or summary tables that are disseminated in any way.
Plans for Archival and Long Term Preservation:
Spatiality
Spatiality (Geographic Locations) yet to be added .....
Dataset
Dataset
Title
Dataset
Description
Dataset yet to be added...
Data Publisher
/Owner
Public Access
Level
Public Access
Justification
External
Access URL
Download
URL
Type of Data
Released
Collection
Start Date
Collection End
Date
File Type | application/pdf |
File Modified | 0000-00-00 |
File Created | 2020-09-29 |